Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Wolff

Showing results (901-910 of 973) with videos related to

Pageof 98
Sort By:
Annals of Surgical Oncology|January 27, 2017
Influence of Preoperative Therapy on Short- and Long-Term Outcomes of Patients with Adenocarcinoma of the Ampulla of VaterJordan M Cloyd, Huamin Wang, Michael Overman, et al.
Cancer Medicine|July 12, 2021
Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patientsChirayu Mohindroo, Merve Hasanov, Jane E Rogers, et al.
The Oncologist|July 17, 2024
Clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinomaMahmoud Yousef, Mark W Hurd, Abdelrahman Yousef, et al.
Plos Pathogens|May 5, 2016
Chemical Genetic Analysis and Functional Characterization of Staphylococcal Wall Teichoic Acid 2-Epimerases Reveals Unconventional Antibiotic Drug TargetsPaul A Mann, Anna Müller, Kerstin A Wolff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2017
<sup>Non-V600</sup> BRAF Mutations Define a Clinically Distinct Molecular Subtype of Metastatic Colorectal CancerJeremy C Jones, Lindsay A Renfro, Humaid O Al-Shamsi, et al.
Annals of Surgery|January 17, 2023
Prognosis Associated With CA19-9 Response Dynamics and Normalization During Neoadjuvant Therapy in Resected Pancreatic AdenocarcinomaTimothy E Newhook, Timothy J Vreeland, James F Griffin, et al.
The Journal of Pediatrics|March 6, 2009
Efficacy of sapropterin dihydrochloride in increasing phenylalanine tolerance in children with phenylketonuria: a phase III, randomized, double-blind, placebo-controlled studyFriedrich K Trefz, Barbara K Burton, Nicola Longo, et al.
Journal for Immunotherapy of Cancer|February 3, 2024
Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinomaRodabe Amaria, Anne Knisely, David Vining, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 2022
Mass Transport Model of Radiation Response: Calibration and Application to Chemoradiation for Pancreatic CancerCharles X Wang, Dalia Elganainy, Mohamed M Zaid, et al.
Clinical and Translational Radiation Oncology|January 31, 2022
NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experienceAlexander F Bagley, Ethan B Ludmir, Anirban Maitra, et al.
Pageof 98

Showing results (901-910 of 973) with videos related to

Sort By:
Pageof 98
Annals of Surgical Oncology|January 27, 2017
Influence of Preoperative Therapy on Short- and Long-Term Outcomes of Patients with Adenocarcinoma of the Ampulla of VaterJordan M Cloyd, Huamin Wang, Michael Overman, et al.
Cancer Medicine|July 12, 2021
Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patientsChirayu Mohindroo, Merve Hasanov, Jane E Rogers, et al.
The Oncologist|July 17, 2024
Clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinomaMahmoud Yousef, Mark W Hurd, Abdelrahman Yousef, et al.
Plos Pathogens|May 5, 2016
Chemical Genetic Analysis and Functional Characterization of Staphylococcal Wall Teichoic Acid 2-Epimerases Reveals Unconventional Antibiotic Drug TargetsPaul A Mann, Anna Müller, Kerstin A Wolff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2017
<sup>Non-V600</sup> BRAF Mutations Define a Clinically Distinct Molecular Subtype of Metastatic Colorectal CancerJeremy C Jones, Lindsay A Renfro, Humaid O Al-Shamsi, et al.
Annals of Surgery|January 17, 2023
Prognosis Associated With CA19-9 Response Dynamics and Normalization During Neoadjuvant Therapy in Resected Pancreatic AdenocarcinomaTimothy E Newhook, Timothy J Vreeland, James F Griffin, et al.
The Journal of Pediatrics|March 6, 2009
Efficacy of sapropterin dihydrochloride in increasing phenylalanine tolerance in children with phenylketonuria: a phase III, randomized, double-blind, placebo-controlled studyFriedrich K Trefz, Barbara K Burton, Nicola Longo, et al.
Journal for Immunotherapy of Cancer|February 3, 2024
Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinomaRodabe Amaria, Anne Knisely, David Vining, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 2022
Mass Transport Model of Radiation Response: Calibration and Application to Chemoradiation for Pancreatic CancerCharles X Wang, Dalia Elganainy, Mohamed M Zaid, et al.
Clinical and Translational Radiation Oncology|January 31, 2022
NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experienceAlexander F Bagley, Ethan B Ludmir, Anirban Maitra, et al.
Pageof 98